Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Vita 34 is Europe's leading private stem cell bank, headquartered in Germany. The company facilitates the secure cryopreservation of umbilical cord blood and tissue stem cells for future medical applications. This provides families with vital preventative care in the field of regenerative medicine.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Vita 34 is scheduled to report its next quarterly earnings on 08/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Vita 34 last reported quarterly earnings on 5/29/2026 (Q1 2026).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.